Publication | Open Access
Structure to function analysis with antigenic characterization of a hypothetical protein, HPAG1_0576 from Helicobacter pylori HPAG1
16
Citations
31
References
2019
Year
Unique Gastric PathogenStructural BioinformaticsBiomolecular Structure PredictionImmunologyGastroenterologyMolecular BiologyPathologyHypothetical ProteinGastrointestinal OncologyH. PyloriProteomicsAntigenic CharacterizationProtein FunctionBiochemistryProtein Structure PredictionGastric CancerTranslational ProteomicsMolecular ModelingProtein BioinformaticsStructural BiologyMolecular MedicineNatural SciencesProtein EngineeringMicrobiologySystems BiologyMedicineHelicobacter Pylori Hpag1
Helicobacter pylori, a unique gastric pathogen causing chronic inflammation in the gastric mucosa with a possibility to develop gastric cancer has one-third of its proteins still uncharacterized. In this study, a hypothetical protein (HP) namely HPAG1_0576 from H. pylori HPAG1 was chosen for detailed computational analysis of its structural, functional and epitopic properties. The primary, secondary and 3D structure/model of the selected HP was constructed. Then refinement and structure validation were done, which indicated a good quality of the newly constructed model. ProFunc and STRING suggested that HPAG1_0576 shares 98% identity with a carcinogenic factor, TNF-α inducing protein (Tip-α ) of H. pylori. IEDB immunoinformatics tool predicted VLMLQACTCPNTSQRNS from position 19-35 as most potential B-cell linear epitope and SFLKSKQL from position 5-12 as most potent conformational epitope. Alternatively, FALVRARGF and FLCGLGVLM were predicted as most immunogenic CD8+ and CD4+ T-cell epitopes respectively. At the same time findings of IFN epitope tool suggests that, HPAG1_0576 had a great potential to evoke interferon-gamma (IFN-γ) mediated immune response. However, this experiment is a primary approach for in silico vaccine designing from a HP, findings of this study will provide significant insights in further investigations and will assist in identifying new drug targets/vaccine candidates.
| Year | Citations | |
|---|---|---|
Page 1
Page 1